Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,102 | 63,584 | 0 | 0 | 0 |
| Marketable Securities | 560 | 226 | 0 | 0 | 0 |
| Other current assets | 1,383 | 0 | 0 | 0 | 0 |
| TOTAL | $55,929 | $65,065 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,423 | 1,691 | N/A | N/A | N/A |
| Intangibles | 175 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 799 | 198 | 0 | 0 | 0 |
| TOTAL | $3,397 | $1,889 | $N/A | $N/A | $N/A |
| Total Assets | $59,326 | $66,954 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,166 | 1,659 | 0 | 0 | 0 |
| Accrued Expenses | 259 | 1,151 | 0 | 0 | 0 |
| Other current liabilities | 2,650 | 2,500 | 0 | 0 | 0 |
| TOTAL | $4,084 | $5,347 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9 | 36 | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,084 | $5,347 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,131 | N/A | N/A | N/A | N/A |
| Common Shares | 20 | 20 | 0 | 0 | 0 |
| Retained earnings | -40,344 | -32,821 | 0 | 0 | 0 |
| TOTAL | $55,242 | $61,607 | $0 | $0 | $0 |
| Total Liabilities And Equity | $59,326 | $66,954 | $0 | $0 | $0 |